Treatment of Renal Anemia in Patients With Hemodialysis Using Hypoxia-inducible Factor (HIF) Stabilizer, Roxadustat: A Short-term Clinical Study

作者
Akira Mima,Yasuhiro Horii
出处
期刊:in Vivo [Stanford University Highwire Press]
卷期号:36 (4): 1785-1789 被引量:17
标识
DOI:10.21873/invivo.12892
摘要

BACKGROUND/AIM: Renal anemia is a major complication in patients with chronic kidney disease (CKD) and hemodialysis, increasing morbidity and mortality. Roxadustat is a novel oral hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor (PHI), which is administrated for renal anemia. Different from erythropoiesis-stimulating agents (ESAs), Roxadustat could increase erythropoietin physiologically, improving the therapeutic effects. It has not been so long since Roxadustat was approved by the European Commission (EC). Thus, only a few studies have reported on the treatment of renal anemia using Roxadustat. PATIENTS AND METHODS: In this study, we evaluated the efficacy of Roxadustat in patients undergoing hemodialysis (HD). Nine patients under HD (72±10 years old) were enrolled in this study. Patients received Roxadustat first time or changed from ESAs (5-10 mg, 3 times a week after HD). Observation period was 5.3±2.9 months. RESULTS: Roxadustat treatment effectively increased and maintained hemoglobin levels. Levels of ferritin and C-reactive protein tended to decrease, but the difference was not statistically significant. No significant adverse effects were observed in all patients during the study. CONCLUSION: Roxadustat is effective and relatively tolerant for treating renal anemia in patients subjected to hemodialysis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Nora发布了新的文献求助10
刚刚
liulanglang完成签到,获得积分10
刚刚
jiuwu完成签到,获得积分10
刚刚
Alcearosea完成签到,获得积分10
1秒前
核桃的应助被rice0601采纳,获得30
1秒前
1秒前
Lionel完成签到,获得积分10
1秒前
2秒前
简qw完成签到,获得积分10
2秒前
2秒前
所所的应助被Chemistry采纳,获得10
2秒前
木子发布了新的文献求助10
2秒前
聪慧芷巧完成签到,获得积分10
2秒前
2秒前
xye关闭了xye的文献求助
2秒前
2秒前
珍珠发布了新的文献求助10
3秒前
lulu发布了新的文献求助20
3秒前
大模型的应助被光亮萤采纳,获得10
3秒前
英俊的铭的应助被维C续航中采纳,获得10
3秒前
4秒前
Jasper的应助被不爱吃鱼采纳,获得10
5秒前
5秒前
一二完成签到,获得积分10
5秒前
lobzzz发布了新的文献求助10
5秒前
酷波er的应助被虚拟的访曼采纳,获得10
5秒前
777发布了新的文献求助10
5秒前
5秒前
Maestro_S的应助被无事小神仙采纳,获得10
6秒前
6秒前
youyuguang发布了新的文献求助10
6秒前
银之吻完成签到 ,获得积分20
6秒前
所所的应助被Ab-Chen采纳,获得30
6秒前
6秒前
Owen的应助被min采纳,获得10
6秒前
SUYIFEI完成签到,获得积分20
7秒前
袁志阳发布了新的文献求助10
8秒前
8秒前
8秒前
sunhealth完成签到,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181072
求助须知:如何正确求助?哪些是违规求助? 9571092
关于积分的说明 21816478
捐赠科研通 7777477
什么是DOI,文献DOI怎么找? 3433418
关于科研通互助平台的介绍 2557638
邀请新用户注册赠送积分活动 2479460